Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Sci Rep ; 9(1): 9562, 2019 07 02.
Article in English | MEDLINE | ID: mdl-31267031

ABSTRACT

Preterm brain injury is highly associated with inflammation, which is likely related in part to sterile responses to hypoxia-ischemia. We have recently shown that neuroprotection with inflammatory pre-conditioning in the immature brain is associated with induction of toll-like receptor 7 (TLR7). We therefore tested the hypothesis that central administration of a synthetic TLR7 agonist, gardiquimod (GDQ), after severe hypoxia-ischemia in preterm-equivalent fetal sheep would improve white and gray matter recovery. Fetal sheep at 0.7 of gestation received sham asphyxia or asphyxia induced by umbilical cord occlusion for 25 minutes, followed by a continuous intracerebroventricular infusion of GDQ or vehicle from 1 to 4 hours (total dose 1.8 mg/kg). Sheep were killed 72 hours after asphyxia for histology. GDQ significantly improved survival of immature and mature oligodendrocytes (2',3'-cyclic-nucleotide 3'-phosphodiesterase, CNPase) and total oligodendrocytes (oligodendrocyte transcription factor 2, Olig-2) within the periventricular and intragyral white matter. There were reduced numbers of cells showing cleaved caspase-3 positive apoptosis and astrogliosis (glial fibrillary acidic protein, GFAP) in both white matter regions. Neuronal survival was increased in the dentate gyrus, caudate and medial thalamic nucleus. Central infusion of GDQ was associated with a robust increase in fetal plasma concentrations of the anti-inflammatory cytokines, interferon-ß (IFN-ß) and interleukin-10 (IL-10), with no significant change in the concentration of the pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α). In conclusion, delayed administration of the TLR7 agonist, GDQ, after severe hypoxia-ischemia in the developing brain markedly ameliorated white and gray matter damage, in association with upregulation of anti-inflammatory cytokines. These data strongly support the hypothesis that modulation of secondary inflammation may be a viable therapeutic target for injury of the preterm brain.


Subject(s)
Asphyxia/metabolism , Gray Matter/drug effects , Gray Matter/metabolism , Neuroprotective Agents/administration & dosage , Premature Birth/metabolism , Toll-Like Receptor 7/agonists , White Matter/drug effects , White Matter/metabolism , Animals , Biomarkers , Blood Gas Analysis , Caspase 3/metabolism , Cell Count , Cell Proliferation , Cytokines/blood , Cytokines/metabolism , Electroencephalography , Hypoxia-Ischemia, Brain/etiology , Hypoxia-Ischemia, Brain/metabolism , Hypoxia-Ischemia, Brain/pathology , Hypoxia-Ischemia, Brain/prevention & control , Immunohistochemistry , Infusions, Intraventricular , Microglia/drug effects , Microglia/metabolism , Oligodendroglia/drug effects , Oligodendroglia/metabolism , Sheep , Time Factors
2.
Dev Neurosci ; 37(6): 497-514, 2015.
Article in English | MEDLINE | ID: mdl-26184807

ABSTRACT

Acute exposure to subclinical infection modulates subsequent hypoxia-ischemia (HI) injury in a time-dependent manner, likely by cross-talk through Toll-like receptors (TLRs), but the specific pathways are unclear in the preterm-equivalent brain. In the present study, we tested the hypothesis that repeated low-dose exposure to lipopolysaccharide (LPS) before acute ischemia would be associated with induction of specific TLRs that are potentially neuroprotective. Fetal sheep at 0.65 gestation (term is ∼145 days) received intravenous boluses of low-dose LPS for 5 days (day 1, 50 ng/kg; days 2-5, 100 ng/kg) or the same volume of saline. Either 4 or 24 h after the last bolus of LPS, complete carotid occlusion was induced for 22 min. Five days after LPS, brains were collected. Pretreatment with LPS for 5 days decreased cellular apoptosis, microglial activation and reactive astrogliosis in response to HI injury induced 24 but not 4 h after the last dose of LPS. This was associated with upregulation of TLR4, TLR7 and IFN-ß mRNA, and increased fetal plasma IFN-ß concentrations. The association of reduced white matter apoptosis and astrogliosis after repeated low-dose LPS finishing 24 h but not 4 h before cerebral ischemia, with central and peripheral induction of IFN-ß, suggests the possibility that IFN-ß may be an important mediator of endogenous neuroprotection in the developing brain.


Subject(s)
Apoptosis/drug effects , Brain/embryology , Hypoxia-Ischemia, Brain/immunology , Lipopolysaccharides/pharmacology , Prenatal Injuries/immunology , Toll-Like Receptor 4/immunology , Toll-Like Receptor 7/immunology , Animals , Brain/immunology , Brain Injuries/immunology , Brain Injuries/prevention & control , Disease Models, Animal , Fetus/drug effects , Fetus/immunology , Interferon-beta/blood , Sheep, Domestic
3.
J Neuroinflammation ; 11: 89, 2014 May 16.
Article in English | MEDLINE | ID: mdl-24886663

ABSTRACT

BACKGROUND: Perinatal asphyxia and exposure to intrauterine infection are associated with impaired neurodevelopment in preterm infants. Acute exposure to non-injurious infection and/or inflammation can either protect or sensitize the brain to subsequent hypoxia-ischemia. However, the effects of subacute infection and/or inflammation are unclear. In this study we tested the hypothesis that acute-on-chronic exposure to lipopolysaccharide (LPS) would exacerbate white matter injury after subsequent asphyxia in preterm fetal sheep. METHODS: Fetal sheep at 0.7 gestational age received a continuous LPS infusion at 100 ng/kg for 24 hours, then 250 ng/kg/24 hours for 96 hours, plus 1 µg boluses of LPS at 48, 72, and 96 hours or the same volume of saline. Four hours after the last bolus, complete umbilical cord occlusion or sham occlusion was induced for 15 minutes. Sheep were sacrificed 10 days after the start of infusions. RESULTS: LPS exposure was associated with induction of microglia and astrocytes and loss of total and immature and mature oligodendrocytes (n = 9) compared to sham controls (n = 9). Umbilical cord occlusion with saline infusions was associated with induction of microglia, astrogliosis, and loss of immature and mature oligodendrocytes (n = 9). LPS exposure before asphyxia (n = 8) was associated with significantly reduced microglial activation and astrogliosis and improved numbers of immature and mature oligodendrocytes compared to either LPS exposure or asphyxia alone. CONCLUSIONS: Contrary to our initial hypothesis, the combination of acute-on-chronic LPS with subsequent asphyxia reduced neuroinflammation and white matter injury compared with either intervention alone.


Subject(s)
Asphyxia Neonatorum/physiopathology , Inflammation/prevention & control , Leukoencephalopathies/prevention & control , Prenatal Exposure Delayed Effects/physiopathology , Animals , Disease Models, Animal , Embryo, Mammalian , Endotoxins/toxicity , Female , Inflammation/etiology , Leukoencephalopathies/etiology , Leukoencephalopathies/pathology , Lipopolysaccharides/toxicity , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Sheep , Time Factors
4.
Neuropharmacology ; 83: 62-70, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24726307

ABSTRACT

Basal ganglia injury after hypoxia-ischemia remains common in preterm infants, and is closely associated with later cerebral palsy. In the present study we tested the hypothesis that a highly selective neuronal nitric oxide synthase (nNOS) inhibitor, JI-10, would improve survival of striatal phenotypic neurons after profound asphyxia, and that the subsequent seizure burden and recovery of EEG are associated with neural outcome. 24 chronically instrumented preterm fetal sheep were randomized to either JI-10 (3 ml of 0.022 mg/ml, n = 8) or saline (n = 8) infusion 15 min before 25 min complete umbilical cord occlusion, or saline plus sham-occlusion (n = 8). Umbilical cord occlusion was associated with reduced numbers of calbindin-28k-, GAD-, NPY-, PV-, Calretinin- and nNOS-positive striatal neurons (p < 0.05 vs. sham occlusion) but not ChAT-positive neurons. JI-10 was associated with increased numbers of calbindin-28k-, GAD-, nNOS-, NPY-, PV-, Calretinin- and ChAT-positive striatal neurons (p < 0.05 vs. saline + occlusion). Seizure burden was strongly associated with loss of calbindin-positive cells (p < 0.05), greater seizure amplitude was associated with loss of GAD-positive cells (p < 0.05), and with more activated microglia in the white matter tracts (p < 0.05). There was no relationship between EEG power after 7 days recovery and total striatal cell loss, but better survival of NPY-positive neurons was associated with lower EEG power. In summary, these findings suggest that selective nNOS inhibition during asphyxia is associated with protection of phenotypic striatal projection neurons and has potential to help reduce basal ganglia injury in some premature babies.


Subject(s)
Aminopyridines/therapeutic use , Asphyxia/complications , Corpus Striatum/drug effects , Enzyme Inhibitors/therapeutic use , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Nitric Oxide Synthase Type I/antagonists & inhibitors , Seizures/drug therapy , Animals , Asphyxia/physiopathology , Corpus Striatum/pathology , Corpus Striatum/physiopathology , Female , Fetal Hypoxia/physiopathology , Fetus , Hypoxia-Ischemia, Brain/pathology , Hypoxia-Ischemia, Brain/physiopathology , Neurons/pathology , Phenotype , Pregnancy , Premature Birth , Seizures/physiopathology , Seizures/radiotherapy , Sheep
5.
PLoS One ; 8(10): e77480, 2013.
Article in English | MEDLINE | ID: mdl-24204840

ABSTRACT

BACKGROUND AND PURPOSE: Maternal glucocorticoid treatment for threatened premature delivery dramatically improves neonatal survival and short-term morbidity; however, its effects on neurodevelopmental outcome are variable. We investigated the effect of maternal glucocorticoid exposure after acute asphyxia on injury in the preterm brain. METHODS: Chronically instrumented singleton fetal sheep at 0.7 of gestation received asphyxia induced by complete umbilical cord occlusion for 25 minutes. 15 minutes after release of occlusion, ewes received a 3 ml i.m. injection of either dexamethasone (12 mg, n = 10) or saline (n = 10). Sheep were killed after 7 days recovery; survival of neurons in the hippocampus and basal ganglia, and oligodendrocytes in periventricular white matter were assessed using an unbiased stereological approach. RESULTS: Maternal dexamethasone after asphyxia was associated with more severe loss of neurons in the hippocampus (CA3 regions, 290 ± 76 vs 484 ± 98 neurons/mm(2), mean ± SEM, P<0.05) and basal ganglia (putamen, 538 ± 112 vs 814 ± 34 neurons/mm(2), P<0.05) compared to asphyxia-saline, and with greater loss of both total (913 ± 77 vs 1201 ± 75/mm(2), P<0.05) and immature/mature myelinating oligodendrocytes in periventricular white matter (66 ± 8 vs 114 ± 12/mm(2), P<0.05, vs sham controls 165 ± 10/mm(2), P<0.001). This was associated with transient hyperglycemia (peak 3.5 ± 0.2 vs. 1.4 ± 0.2 mmol/L at 6 h, P<0.05) and reduced suppression of EEG power in the first 24 h after occlusion (maximum -1.5 ± 1.2 dB vs. -5.0 ± 1.4 dB in saline controls, P<0.01), but later onset and fewer overt seizures. CONCLUSIONS: In preterm fetal sheep, exposure to maternal dexamethasone during recovery from asphyxia exacerbated brain damage.


Subject(s)
Anti-Inflammatory Agents/adverse effects , Asphyxia/pathology , Dexamethasone/adverse effects , Neurons/drug effects , Oligodendroglia/drug effects , Animals , Asphyxia/drug therapy , Basal Ganglia/drug effects , Basal Ganglia/pathology , Cell Count , Cell Death , Cerebral Ventricles/drug effects , Cerebral Ventricles/pathology , Electroencephalography , Female , Fetus , Hippocampus/drug effects , Hippocampus/pathology , Injections, Intramuscular , Neurons/pathology , Oligodendroglia/pathology , Pregnancy , Premature Birth/pathology , Sheep , Sheep, Domestic , Umbilical Cord/pathology
6.
Recent Pat CNS Drug Discov ; 8(2): 142-60, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23597305

ABSTRACT

Ischemic brain damage remains a major cause of disability at all ages. This review examines the efficacy, mode of action and mechanisms of insulin-like growth factor (IGF)-1 and its derivatives in animal models of acute brain injury and neurodegenerative conditions, their potential in pharmaceutical developments. IGF-1 reduces cell loss and improves long-term neurological function in animal models. IGF-1 needs to be given within a few hours of the insult. However, the therapeutic window can be extended by mild hypothermia, likely by delaying apoptosis. Nevertheless, the poor central uptake of IGF-1 and its mitogenic potential limit clinical translation. Thus, recent studies have examined related compounds. For example, intravenous infusion of the N-terminal tripeptide of IGF-1 (glycine- proline-glutamate, GPE) can alleviate brain injury and improve long-term function in rats, with a broad effective dose range and a 3-7 hour therapeutic window, but has a short half-life. G-2meth-PE(G-2mPE), a GPE analogue with a longer half-life, is also neuroprotective. GPE/G-2mPE do not interact with IGF receptors and may act by modulating postinjury inflammation, astrogliosis and vascular remodeling. Cyclo-glycyl-proline (cGP), an endogenous diketopiperazine possibly derived from GPE is also neuroprotective. An analogue, cyclo-L-glycyl-L-2-allylproline (NNZ-2591) improves long-term somatosensory-motor function and histology after ischemic injury. Treatment with NNZ-2591 after 6-hypdroxydopamine injection in adult rats improves neurogenesis and long-term motor function. Further, oral administration of NNZ-2591 also prevents scopolamine-induced acute memory impairment. These beneficial effects may mediated by improved neuroplasticity. This review is an updated version of a previous publication in Recent Pat CNS Drug Discov.


Subject(s)
Drug Evaluation, Preclinical , Insulin-Like Growth Factor I/analogs & derivatives , Insulin-Like Growth Factor I/therapeutic use , Nervous System Diseases/drug therapy , Animals , Brain/drug effects , Insulin-Like Growth Factor I/pharmacology , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Recovery of Function/drug effects
7.
Am J Physiol Regul Integr Comp Physiol ; 304(3): R189-97, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23235324

ABSTRACT

Acute, high-dose exposure to endotoxin lipopolysaccharide (LPS) in preterm fetal sheep can trigger periventricular white matter lesions (PVL), in association with severe hypotension/hypoxemia and significant mortality. Intriguingly, however, chronic or repeated exposure to LPS can induce tachyphylaxis. We therefore tested the hypothesis that progressive, acute on chronic fetal infection would be associated with white matter injury with little fetal mortality. Chronically instrumented preterm (0.7 gestational age) fetal sheep were exposed to a continuous low-dose LPS infusion (100 ng over 24 h, followed by 250 ng/24 h for 96 h) or saline. Boluses of 1 µg LPS or saline were given at 48, 72, and 96 h; sheep were killed at day 10. Six of 11 fetal sheep exposed to saline infusion + LPS boluses died 4-7 h after the first bolus. In contrast, there was no fetal mortality after saline infusions alone (n = 9), low-dose LPS infusion + saline boluses (n = 5), or low-dose LPS + LPS boluses (n = 9). Low-dose LPS infusion + LPS boluses was associated with greater microglial induction than low-dose LPS + saline boluses but a similar area of periventricular white matter inflammation. One fetus developed severe focal white matter necrosis after LPS infusion + boluses. The acute cardiovascular compromise associated with high-dose, acute exposure to LPS is markedly attenuated by previous low-dose infusions, with limited apparent exacerbation of periventricular white matter injury compared with low-dose infusion alone.


Subject(s)
Brain/drug effects , Brain/physiopathology , Endotoxins/toxicity , Nerve Fibers, Myelinated/drug effects , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/physiopathology , Animals , Animals, Newborn , Dose-Response Relationship, Drug , Female , Male , Pregnancy , Premature Birth , Sheep , Survival Rate , Toxicity Tests, Acute , Toxicity Tests, Chronic
8.
CNS Neurosci Ther ; 18(11): 887-94, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22998294

ABSTRACT

AIMS: Oxidative stress is an early event in the cascade leading in neuronal damage after hypoxic-ischemic (HI) brain injury. In the present study, we examined the dose response and window of opportunity for neuroprotection after HI injury with Allene Oxide Synthase (AOS), an anti-oxidative enzyme of the member of cytochrome P450 family. METHODS: Adult male rats received intra-cerebro-ventricular infusions of either saline (vehicle) or AOS (1 µg or 10 µg or 100 µg per rat, intracerebroventricular n = 16 all groups) either 45 min or 3 h after unilateral HI brain injury. Brains were collected 5 days later. The extent of brain damage, neuronal survival, apoptosis, and glial reactions were assessed in the striatum, hippocampus, and cortex. RESULTS: Allene Oxide Synthase was associated with reduced neuronal damage scores when given 45 min, but not 3 h, after HI injury (P < 0.0001) in all brain regions. AOS treatment (10 µg) improved neuronal survival in the striatum, cortex, and hippocampus (P < 0.05, P < 0.001) and reduced the microglia reaction (P < 0.05) and numbers of caspase-3-positive cells in the hippocampus (P < 0.01). CONCLUSIONS: Early blockade of oxidative stress after HI injury reduces inflammatory response, neuronal necrosis, and apoptosis. The neuroprotective effects of AOS were time of administration-dependent suggesting a relatively restricted window of opportunity for acute brain injury.


Subject(s)
Antioxidants/administration & dosage , Hypoxia-Ischemia, Brain/enzymology , Hypoxia-Ischemia, Brain/prevention & control , Intramolecular Oxidoreductases/administration & dosage , Neuroprotective Agents/administration & dosage , Age Factors , Animals , Hypoxia-Ischemia, Brain/pathology , Infusions, Intraventricular , Male , Rats , Rats, Wistar , Time Factors
9.
Stroke ; 43(11): 3114-7, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22923445

ABSTRACT

BACKGROUND AND PURPOSE: Hypothermia induced after perinatal hypoxia-ischemia is partially protective. This study examined whether early treatment with the noncompetitive N-methyl-d-aspartate receptor antagonist, dizocilpine, can augment neuroprotection with delayed hypothermia after severe asphyxia in preterm fetal sheep at 0.7 weeks gestation (equivalent to 28-32 weeks in humans). METHODS: Fifty minutes after umbilical cord occlusion for 25 minutes, fetuses were randomized to either dizocilpine (2 mg/kg estimated fetal weight intravenously, then 0.07 mg/kg/h for 4 hours) and then after 5.5 hours to whole-body cooling to 3°C below baseline, or sham cooling, until 72 hours, and euthanized 7 days after umbilical cord occlusion. RESULTS: Delayed hypothermia was associated with improved neuronal survival (P<0.02) and reduced microglia (P=0.004) and caspase-3-positive cells (P<0.01) compared with umbilical cord occlusion. Dizocilpine was associated with reduced microglia (P<0.05) but no effect on caspase-3 induction and improved survival only in CA1/2 (P<0.05) with no apparent additive effect with delayed hypothermia. CONCLUSIONS: Early N-methyl-d-aspartate blockade and a clinical regime of delayed whole-body hypothermia provide nonadditive neuroprotection in the preterm brain.


Subject(s)
Dizocilpine Maleate/pharmacology , Hypothermia, Induced , Hypoxia-Ischemia, Brain/pathology , Neuroprotective Agents/pharmacology , Animals , Asphyxia/complications , Excitatory Amino Acid Antagonists/pharmacology , Fetus , Hypoxia-Ischemia, Brain/metabolism , Sheep
10.
Am J Physiol Regul Integr Comp Physiol ; 303(3): R270-8, 2012 Aug 01.
Article in English | MEDLINE | ID: mdl-22696578

ABSTRACT

Exposure to chorioamnionitis is strongly associated with neurodevelopmental disability after premature birth; however, it remains unclear whether subclinical infection affects functional EEG maturation. Chronically instrumented 103-104-day-old (0.7 gestational age: term 147 days) fetal sheep in utero were randomized to receive either gram-negative LPS by continuous low-dose infusion (100 ng iv over 24 h, followed by 250 ng/24 h for 4 days; n = 6) or the same volume of normal saline (n = 9). Arterial plasma cortisol, ACTH, and IL-6 were measured. The delta (0-3.9 Hz), theta (4-7.9 Hz), alpha (8-12.9 Hz), and beta (13-22 Hz) components of the EEG were determined by power spectral analysis. Brains were taken after 10 days for histopathology. There were no changes in blood gases, cardiovascular variables, or EEG power during LPS infusion, but a transient rise in plasma cortisol and IL-6 (P < 0.05). LPS infusion was associated with loss of the maturational increase to higher frequency activity, with reduced alpha and beta power, and greater delta power than saline controls from 6 to 10 days (P < 0.05). Histologically, LPS was associated with increased numbers of microglia and TNF-α-positive cells in the periventricular white matter and frontoparietal cortex, increased caspase-3-positive cells in white matter, but no loss of CNPase-positive oligodendrocytes, Nurr-1 subplate cells, or gyral complexity. These data suggest that low-dose endotoxin exposure can impair EEG maturation in preterm fetal sheep in association with neural inflammation but without hemodynamic disturbances or cortical injury.


Subject(s)
Brain/drug effects , Brain/embryology , Electroencephalography/drug effects , Endotoxins/pharmacology , Fetus/drug effects , Fetus/embryology , Alpha Rhythm/drug effects , Alpha Rhythm/physiology , Animals , Beta Rhythm/drug effects , Beta Rhythm/physiology , Brain/cytology , Caspase 3/metabolism , Delta Rhythm/drug effects , Delta Rhythm/physiology , Dose-Response Relationship, Drug , Female , Fetus/physiology , Lipopolysaccharides/pharmacology , Microglia/cytology , Models, Animal , Pregnancy , Sheep , Tumor Necrosis Factor-alpha/metabolism
11.
Pediatr Res ; 71(4 Pt 1): 345-53, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22391634

ABSTRACT

INTRODUCTION: This study examined whether spectral analysis of the electroencephalogram (EEG) can discriminate between mild and severe hypoxic-ischemic injury in the immature brain. RESULTS: Total EEG power was profoundly suppressed after umbilical cord occlusion and recovered to baseline by 5 h after 15-min of occlusion, in contrast with transient recovery in the 25-min (P < 0.05). Power spectra were not different between groups in the first 3 h; α and ß power were significantly higher in the 15-min group from 4 h, and Δ and θ power from 5 h (P < 0.05). The 25-min group showed severe neuronal loss in hippocampal regions and basal ganglia at 3 days, in contrast with no/minimal injury in the 15-min group. DISCUSSION: EEG power after asphyxia did not discriminate between mild and severe injury in the first 3 h in preterm fetal sheep. Severe subcortical neural injury was associated with persistent loss of high-frequency activity. METHODS: Chronically instrumented fetal sheep at 0.7 gestation (101-104 days; term is 147 days) received either 15-min (n = 13) or 25-min (n = 13) of complete umbilical cord occlusion. The Δ (0-3.9 Hz), θ (4-7.9 Hz), α (8-12.9 Hz), and ß (13-22 Hz) components of the EEG were determined by power spectral analysis. Brains were taken at 3 days for histopathology.


Subject(s)
Asphyxia/metabolism , Brain/embryology , Electroencephalography/methods , Pregnancy, Animal , Animals , Carbon Dioxide/chemistry , Electromyography/methods , Female , Hippocampus/pathology , Hypoxia/pathology , Ischemia/pathology , Neurons/pathology , Perfusion , Predictive Value of Tests , Pregnancy , Sheep , Time Factors , Umbilical Cord/pathology
12.
Neurosci Lett ; 454(1): 53-7, 2009 Apr 17.
Article in English | MEDLINE | ID: mdl-19429053

ABSTRACT

We have previously reported that peripheral administration of GPE prevents neuronal injury after ischemic reperfusion injury in young adult rats. This study examined the ameliorating effects of GPE-treatment after embolic injury induced by microsphere injection in young adult and aged male rats. Unilateral injury was induced by injecting microspheres into the right internal carotid artery in both young adult (3-4 months) and aged (16-17 months) male rats. Either GPE (12mg/kg) or the vehicle was infused intravenously over 1h starting 3h after embolic injury and the degree of brain injury, astrocytosis and vascular remodeling were examined using histological and immunohistochemical analysis 8 days later. Changes in core temperature, blood glucose concentration, oxygen saturation and heart rate were monitored. Microsphere injection induced multiple sites of focal damage in the ipsilateral subcortical regions. Massive numbers of microglia accumulated within the core of the tissue damage whereas astrocytes were located in the penumbra. There was no difference in the degree of brain injury between the young and aged control rats. However the aged rats showed less injury-induced astrocytosis and greater vascular remodeling. Intravenous infusion of GPE 3h after the injury reduced overall damage scores in both young (p<0.01) and aged rats (p<0.05). GPE-treatment reduced astrocytosis in young, but not aged animals and did not significantly alter the vascular remodeling in either age group. The data suggested that the neuroprotection of the tripeptide is independent of cerebral reperfusion and is not age selective.


Subject(s)
Neuroprotective Agents/administration & dosage , Oligopeptides/administration & dosage , Reperfusion Injury/drug therapy , Reperfusion Injury/pathology , Age Factors , Animals , Drug Administration Schedule , Immunohistochemistry , Insulin-Like Growth Factor I/chemistry , Intracranial Embolism/complications , Intracranial Embolism/pathology , Intracranial Embolism/physiopathology , Male , Microspheres , Rats , Reperfusion Injury/etiology
13.
Exp Gerontol ; 43(10): 929-38, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18761081

ABSTRACT

We describe neuronal density, neuroplasticity and vascular remodelling and their association with spatial memory in young (4-6 months), middle-aged (9-11 months) and aged (18-20 months) rats of both genders. The neuronal density was reduced in the hippocampus of middle-aged and aged rats, particularly in male rats. However the loss of spatial memory investigated using the Morris water maze, T-maze and 8-radial arm maze tests was found only in the aged groups. The data suggested a pre-symptomatic period of pathological brain aging. Surprisingly, the middle-aged groups showed an elevation of glutamate-decarboxylase immunoreactive neurons in the hippocampus and the striatum, an increase of dopamine output in the striatum and enhanced vascular remodelling in the hippocampus when compared with the young and, in some cases, aged groups. Together, the data suggest that the loss of neurons during midlife may stimulate and enhance neuronal plasticity and vascular remodelling. These compensatory responses to initial neuronal degeneration may play a role in delaying impending memory loss during the pre-symptomatic period of pathological brain aging.


Subject(s)
Aging/physiology , Glutamate Decarboxylase/metabolism , Hippocampus/physiopathology , Memory Disorders/physiopathology , Neuronal Plasticity/physiology , Animals , Female , Hippocampus/enzymology , Male , Maze Learning , Memory Disorders/enzymology , Rats , Rats, Wistar , Spatial Behavior
14.
Dev Neurosci ; 29(4-5): 393-402, 2007.
Article in English | MEDLINE | ID: mdl-17762207

ABSTRACT

Glycine 2-methyl proline glutamate (G-2mPE) is a proline-modified analogue to the naturally existing N-terminal tripeptide glycine-proline-glutamate that is a cleaved product from insulin-like growth factor-1. G-2mPE is designed to be more enzymatically resistant than glycine-proline-glutamate and to increase its bioavailability. The current study has investigated the protective effects of G-2mPE following hypoxic-ischemic brain injury in the neonatal brain. On postnatal day 7, Wistar rats were exposed to hypoxia-ischemia (HI). HI was induced by unilateral ligation of the left carotid artery followed by hypoxia (7.7% O2, 36 degrees C) for 60 min. The drug treatment started 2 h after the insult, and the pups were given either 1.2 mg/kg (bolus), 1.2 mg/ml once a day for 7 days, or vehicle. The degree of brain damage was determined histochemically by thionin/acid fuchsin staining. G-2mPE's anti-inflammatory properties were investigated by IL-1beta, IL-6, and IL-18 ELISA, and effects on apoptosis by caspase 3 activity. Vascularization was determined immunohistochemically by the total length of isolectin-positive blood vessels. Effect on astrocytosis was also determined in the hippocampus. Animals treated with multiple doses of G-2mPE demonstrated reduced overall brain injury 7 days after HI, particularly in the hippocampus and thalamus compared to vehicle-treated rats. The expression of IL-6 was decreased in G-2mPE-treated animals compared to vehicle-treated pups, and both the capillary length and astrogliosis were increased in the drug-treated animals. There was no effect on caspase 3 activity. This study indicates that peripheral administration of G-2mPE, starting 2 h after a hypoxic-ischemic insult, reduces the degree of brain injury in the immature rat brain. The normalization of IL-6 levels and the promotion of both neovascularization and reactive astrocytosis may be potential mechanisms that underlie its protective effects.


Subject(s)
Birth Injuries/drug therapy , Encephalitis/drug therapy , Hypoxia-Ischemia, Brain/drug therapy , Nerve Degeneration/drug therapy , Neuroprotective Agents/pharmacology , Oligopeptides/pharmacology , Animals , Animals, Newborn , Apoptosis/drug effects , Apoptosis/physiology , Astrocytes/drug effects , Astrocytes/physiology , Birth Injuries/pathology , Birth Injuries/physiopathology , Brain/blood supply , Brain/drug effects , Brain/physiopathology , Caspase 3/drug effects , Caspase 3/metabolism , Cerebral Arteries/drug effects , Cerebral Arteries/growth & development , Disease Models, Animal , Drug Administration Schedule , Encephalitis/pathology , Encephalitis/physiopathology , Gliosis/drug therapy , Gliosis/pathology , Gliosis/physiopathology , Hypoxia-Ischemia, Brain/pathology , Hypoxia-Ischemia, Brain/physiopathology , Interleukins/metabolism , Neovascularization, Physiologic/drug effects , Neovascularization, Physiologic/physiology , Nerve Degeneration/pathology , Nerve Degeneration/physiopathology , Neuroprotective Agents/therapeutic use , Oligopeptides/therapeutic use , Rats , Rats, Wistar , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...